Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 195 of 1,261

  1. US 11649261

    Crystalline forms of a CD73 inhibitor and uses thereof

    Arcus Biosciences, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  2. US 11648232

    Methods and compositions for treating excessive sleepiness

    AXSOME MALTA LTD. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  3. US 11648297

    Bioresponsive particles

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted

  4. US 11649237

    Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition

    The Regents of the University of California · Granted May 16, 2023 · Expires May 11, 2043

    granted

  5. US 11648287

    Composition for the treatment of intracellular bacterial infection

    ACADEMISCH MEDISCH CENTRUM · Granted May 16, 2023 · Expires May 11, 2043

    granted

  6. US 11648272

    Human kynureninase enzymes and uses thereof

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted

  7. US 11649454

    Single-stranded RNA-editing oligonucleotides

    ProQR Therapeutics II B.V. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  8. US 11649209

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted May 16, 2023 · Expires May 11, 2043

    granted

  9. US 11648307

    Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted

  10. US 11649239

    Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

    Medshine Discovery Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  11. US 11649207

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  12. US 11648302

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 16, 2023 · Expires May 11, 2043

    granted

  13. US 11647776

    Extract, consumable product and method for enriching bioactive metabolite in an extract

    Brightseed, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  14. US 11648209

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted

  15. US 11648211

    Nanoencapsulated combination drug formulations

    Northwestern University · Granted May 16, 2023 · Expires May 11, 2043

    granted

  16. US 11648245

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted May 16, 2023 · Expires May 11, 2043

    granted

  17. US 11649273

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  18. US 11648247

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  19. US 11642319

    Targeted nanogels for urinary bladder therapies

    The Regents of the University of Colorado · Granted May 9, 2023 · Expires May 4, 2043

    granted

  20. US 11642384

    Compositions and methods for the treatment of Netherton Syndrome

    Krystal Biotech, Inc. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  21. US 11642354

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted

  22. US 11642374

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2023 · Expires May 4, 2043

    granted

  23. US 11642332

    (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted May 9, 2023 · Expires May 4, 2043

    granted

  24. US 11642366

    Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

    GLYCOMIRA THERAPEUTICS, INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.